Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Jersey for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Jersey only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Jersey (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Vincent Ho (NPI 1720390891)

Field	Value
Entity Type	Individual
Organization	Vincent Ho
Address	628 Cedar Ln
City	Teaneck
State	NJ
ZIP	07666
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	July 6, 2010

Payer Source	Total Paid
Medicare	$2.4M
Medicaid	$0

Key Findings

Specialty and service mix point to an in-office medical retina practice: the top revenue drivers are intravitreal biologic and anti-VEGF products (J0178 and J2777) plus high-volume comprehensive ophthalmology exams (92014). J0178 generated $974.3K (40.5% of Medicare revenue) and J2777 generated $436.7K (18.1%), while the procedure mix includes injection codes such as 67028 ($133.3K) and retinal imaging like 92134 ($74.2K), consistent with recurrent injection clinics that combine procedural therapy with diagnostic imaging and follow-up visits.

Revenue concentration is high: the precomputed top 3 Medicare codes by revenue account for 67.4% of this provider's total Medicare revenue. Those top three are J0178 (40.5%), J2777 (18.1%), and 92014 (8.8%), indicating most Medicare dollars flow from a small set of biologic injections and established-patient comprehensive exams.

This provider is effectively single-payer in the dataset: Total Medicare revenue is $2.4M while Total Medicaid revenue is none, with no Medicaid billing on file. The absence of Medicaid activity means the practice’s patient mix and revenue exposure are concentrated on Medicare beneficiaries and Medicare reimbursement dynamics.

Competitive standing varies by service line: 92014 is an extreme outlier nationally (ranks #232 of 35415 providers nationally (99th percentile; extreme outlier, far above typical national volume for this code)), signaling an unusually large volume of comprehensive established-patient visits compared with peers. High relative volume for 92134 (ranks #928 of 26868 providers nationally (97th percentile; notably above typical national volume for this code)) and 92202 (ranks #75 of 2327 providers nationally (97th percentile; notably above typical national volume for this code)) further supports that this provider performs more diagnostic and exam visits than most peers.

By contrast, the provider’s injection drug volumes are typical to modest versus national peers: J0178 ranks #888 of 3204 providers nationally (72th percentile; typical, unremarkable volume for this code), J2777 ranks #713 of 2039 providers nationally (65th percentile; typical, unremarkable volume for this code), and J2778 ranks #443 of 1208 providers nationally (63th percentile; typical, unremarkable volume for this code). These percentiles indicate the practice is not a dominant national provider of anti-VEGF injections despite these codes driving much of its revenue.

Unit economics show concentration in a few high-dollar items: J0178 has $690 avg paid/claim and produced $974.3K, while J3590 (unclassified biologics) has a $2386 avg paid/claim and generated $190.9K. J2777 shows a very large claim count (15.1K claims) with a low $29 avg paid/claim producing $436.7K, which indicates different per-claim reimbursement dynamics across biologic/drug codes that materially affect total Medicare revenue.

Operationally, the practice bills a mix of procedure, imaging, and evaluation codes consistent with longitudinal management of retinal disease: frequent use of 67028 (1.3K claims, $104 avg paid/claim, $133.3K) for intravitreal injections, and diagnostic codes like 92134 (2.1K claims, $35 avg paid/claim, $74.2K) align with follow-up imaging and treatment cycles in retinal care. The presence of both high-volume exam code 92014 (2K claims, $104 avg paid/claim, $211.7K) and injection procedure codes suggests bundled clinic workflows that alternate imaging/assessment visits with intravitreal therapy.

Tenure data show an established practice footprint: NPI enumerated 2010-07-06 (~16 years ago), indicating the provider has been active long enough to build a stable Medicare patient panel and recurring-treatment workflows that are reflected in the concentrated revenue profile.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

19 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,410	$690	$974.3K
J2777	Injection, faricimab‑svoa, 0.1 mg	15,060	$30	$436.7K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	2,040	$100	$211.7K
J3590	Unclassified biologics	80	$2,390	$190.9K
J2778	Injection, ranibizumab, 0.1 mg	970	$190	$181.4K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,280	$100	$133.3K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,120	$40	$74.2K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	330	$210	$70K
J3490	Unclassified drugs	30	$1,760	$49.3K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	210	$120	$25.2K

Showing 1–10 of 19

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Jersey Distribution

Vincent Ho — 3 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Jersey

Full comparison — all codes billed, vs. state median

19 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	24	90	880	$690	$693.6K
J2777	12	60	8,820	$30	$319K
J2778	25	40	1,140	$180	$240.8K
J3590	7	20	50	$2,180	$156.6K
Q5128	11	20	650	$210	$139K
67028	33	100	810	$100	$91.1K
J2781	18	20	570	$120	$88.8K
92014	21	1,130	160	$100	$34.9K
J3490	99	120	70	$230	$30.2K
92012	610	800	140	$70	$18.5K

Showing 1–10 of 19

Related Providers

Other providers that share a Tax Identification Number (TIN) with Vincent Ho, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Associated Retinal Consultants LLC	DE	Ophthalmology Physician	$0	$25.2M
Rohit Lakhanpal	MD	Retina Specialist (Ophthalmology) Physician	$6.1M	$0
Vinod Voleti	NJ	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Sumit Shah	NJ	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Newman Sund	MD	Ophthalmology Physician	$4M	$0
Eric Suan	MD	Ophthalmology Physician	$3.8M	$0
Matthew Speicher	MD	Ophthalmology Physician	$3.7M	$0
Howard Fine	NJ	Retina Specialist (Ophthalmology) Physician	$3.6M	$0
Timothy Polk	MD	Ophthalmology Physician	$3.5M	$0
Jonathan Prenner	NJ	Retina Specialist (Ophthalmology) Physician	$3.4M	$0

Nearby Providers

Other providers in the same ZIP code as Vincent Ho, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Holy Name Medical Center Inc.	NJ	General Acute Care Hospital	$0	$107.1M
Awca Home Care Agency, Inc.	NJ	Home Health Agency	$0	$25.2M
Care-4-me,llc	NJ	Home Health Agency	$0	$18.1M
Excelcare Medical Associates, PA	NJ	Internal Medicine Physician	$0	$10M
Friendly Urgent Care, LLC	NJ	Urgent Care Clinic/Center	$0	$8.6M
New Jersey Laser Dentistry	NJ	Dental Clinic/Center	$0	$8.5M
Holy Name Ems	NJ	Land Ambulance	$1.3M	$919K
Tamara Lenis	NJ	Ophthalmology Physician	$1.7M	$0
Neil Gonter	NJ	Rheumatology Physician	$1.6M	$0
Luis Gonzalez Gonzalez	NJ	Ophthalmology Physician	$1.5M	$0

Vincent Ho — Billing Profile & Reimbursement Data

Sign up for Vincent Ho — Billing Profile & Reimbursement Data policy alerts

Vincent Ho — Billing Profile & Reimbursement Data

Sign up for Vincent Ho — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References